Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 390

PDF Downloaded: 118


Get Permission Nerkar, Nagarkar, and Badar: Ethnopharmacological review of turmeric for anticancer activity


Introduction

Turmeric, or Curcuma longa Lin.,1 belongs to the Zingiberaceae plant family. The plant has a lot of potential in terms of medicinal properties.2, 3 It has a number of beneficial qualities including those of anti-inflammatory, biliary, hepatoprotective, blood purifier, antioxidan t, detoxifying and regenerating liver tissue, anti-asthmatic, anti-cancer, anti-toxin, digestion and carminative, as noted in the literature.4, 5, 6, 7, 8, 9 Plasma cholesterol levels can be lowered using curcumin. The heart and arteries are preserved by its antiplatelet activity. It also protects against DNA damage in lymphocytes.10 The parts of this plant contain curcumin, a type of flavonoid. About 60-70% of turmeric powder is made up of carbohydrates, while other ingredients include 6-8% protein, 5-8%, 3-7% minerals, 3-7% essential oils, 2-7% fiber11 and 1-6% curcuminoids. The phytochemicals in turmeric are found in Diarylheptanoids, a different group of curcuminoids that includes curcumin, demethoxycurcumin, and bisdemethoxycurcumin.12 It was also observed that Zingiber officinale Roscoe and Curcuma longa Linnaeus are the two main species of Zingiberaceae studied for a variety of pharmaceuticals, including anti-inflammatory, anti-angiogenic, antibacterial, analgesic, immunomodulatory, pro-apoptotic, anti-HIV and anti-cancer.13 Further some researchers also found that the Curcumin is a polyphenol natural product isolated from turmeric, interacting with different cellular and molecular targets and, consequently, showing a wide range of pharmacological effects.14 Taxanomical Classification.

  1. Kingdom: Plantae

  2. Subkingdom: Tracheobionta

  3. Super division: Spermatophyta

  4. Division: Magnoliophyta

  5. Subclass: Zingiberidae

  6. Order: Zingiberales

  7. Family: Zingiberaceae

  8. Genus: Curcuma

  9. Species: longa

  10. Scientific name: Curcuma longa

Geographical distribution15

  1. World scenario: It is commonly found in Cambodia, China, India, Nepal, Indonesia, Madagascar, Malaysia, Philippines and Viet Nam.

  2. India scenario: It is commonly found in West Bengal, Tamil Nadu, and Maharashtra and also in Madras.

  3. History: In the year the Vedic civilization of India, it was used as a culinary spice and has some religious significance, turmeric has been used for about 4000 years. By AD 700, it could have spread to China, East Africa, West Africa, and Jamaica. In 1200 AD, it may have reached China. Marco Polo wrote about this spice in 1280, showing a vegetable very close in character to saffron. Turmeric has a long history of medicinal use in South Asia, according to Sanskrit medical texts, Ayurvedic and Unani traditions. An ointment containing turmeric is suggested in the Ayurvedic compendium of Sushruta, dating back to 250 BC. In AD, it was used to treat the effects of contaminated food.16

Cultivation16, 17

  1. Climate: For proper growth, the turmeric plant requires temperatures between 20°C and 30°C as well as a good amount of annual rainfall. Individual plants have long, oblong leaves and can reach a height of 1 m. Both the tropics and the subtropics are suitable for growing the tropical herb turmeric. If the shade is not too dense, it will grow lushly, but on open land that is exposed to the light, it generates bigger and better rhizomes. Turmeric needs a humid environment.

  2. Soil: The soil should be rich and friable while growing turmeric. Suitable soils have a slightly higher sand content. It is grown in a variety of soil types, from clay loams to light black, sandy loam, and red soils. It thrives in irrigated and rain-fed locations on light black, ashy loam, red soils, and stiff loams.

  3. Harvesting: Typically, the harvest season is from January until March or April. Early and medium varieties reach maturity in 7-8 and 8-9 months, respectively. The crop is ready to be cut when the leaves begin to dry out and turn yellow. When the plant reaches maturity, the leaves are removed just above the soil, the earth is tilled, and rhizomes are collected by hand plucking or by carefully lifting the clumps with a spade.

  4. Irrigation: The amount of irrigations for turmeric will depend on the soil and weather. In medium-heavy soils, 15 to 25 irrigations are supplied, while in red soils with a light texture, 35 to 40 irrigations are required. Rhizomes for seed are typically piled up and covered with turmeric leaves under trees or in sheds with good ventilation. The seed rhizomes can also be kept in sawdust-filled pits.

Health benefits/Uses1 9, 10, 11, 12, 13, 14, 1, 15, 16, 17, 18, 19, 20

  1. Turmeric promotes balanced mood.

  2. Turmeric helps wounds healing.

  3. Turmeric group seemed to enjoy more relief from joint pain.

  4. Turmeric helps in balanced blood sugar

  5. Leprosy, dysentery, heart disease, jaundice, diabetes, lactation antimicrobials, and antioxidants.

  6. They have been used for rheumatism, diabetes, stomach ulcers, hepatic disorders, boils, skin conditions, enlarged liver, spleen, and chest pain, among other traditional medical conditions.

  7. Older research indicates that curcumin has antimicrobial, anti-inflammatory, dyspepsia and gastric ulcer, irritable bowel syndrome, pancreatitis, rheumatoid arthritis, osteoarthritis, and antioxidant properties.

  8. It is also the primary active component of all curcuma plants and is responsible for the yellow colour of curcuma.

Side effects, contraindications and precautions21, 22, 23, 24, 25

  1. The patient facing gall bladder is recommended not to eat turmeric.

  2. If any patient had bleeding problems, it is recommended to steer clear of turmeric.

  3. High doses of turmeric cause uterine contraction in pregnant women.

  4. Turmeric might lower testosterone levels and decrease sperm movement when taken by mouth by men.

  5. Turmeric might slow blood clotting so stop using it at least two weeks before a scheduled surgery.

  6. Taking high amounts of turmeric might prevent the absorption of iron. So it should be used with caution in people with iron deficiency.

Chemical Constituents of Turmeric26, 27, 28

Figure 1

Curcumin

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5a7927f3-5539-425e-aa3c-28159f98c329image1.png

The active constituent of Turmeric is shown in the figure viz Curcumin. Further the following are the active constituents of Turmeric, in a standard form, turmeric contains moisture (>9%), curcumin (5–6.6%), extraneous matter (<0.5% by weight), mould (<3%), and volatile oils (<3.5%). Volatile oils include d-α-phellandrene, d-sabinene, cinol, borneol, zingiberene, and sesquiterpenes). The active constituents of turmeric are shown in Figure below. Curcumin, the active ingredient in the Curcuma longa plant, has received a lot of attention over the past two decades as an antioxidant, anti-inflammatory, and anti-cancer agent. In this review, a summary of the pharmacochemistry and pharmacology of curcumin and its derivatives for their antitumor activity, their main mechanisms of action, and cellular targets has been provided based on Data from the literature from experimental and clinical reviews of curcumin in cancer cell lines, animal models and human subjects showed promising results.

Figure 2

Active constituents of Turmeric

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5a7927f3-5539-425e-aa3c-28159f98c329image2.png

Review for Anticancer Activity of Turmeric

Through its effects on several biological pathways involved in mutation, oncogene expression, cell cycle regulation, apoptosis, tumorigenesis, and metastasis, curcumin has been proven to have anti-cancer properties. Curcumin inhibits NF-B transcription factor and downstream gene products, and has demonstrated anti-proliferative effects in several malignancies (including c-myc, Bcl-2, COX-2, NOS). , Cyclin D1,29 TNF-α, 30 interleukin and MMP-9). Various growth factor receptors and cell adhesion molecules involved in tumor growth, angiogenesis, and metastasis are also affected by curcumin. By modifying the deregulated cell cycle by,

  1. Cyclin-dependent31

  2. p53-dependent and32

Curcumin demonstrates its anti-tumor effects in cancer cells. Because of its effects on key cell cycle signaling pathways and its success in animal model systems, curcumin has been recognized as a multifaceted weapon in the fight against cancer.33 deadly cancer. Natural phytochemicals such as curcumin could connect to these new targets and synergize with chemotherapy. Curcumin is also well tolerated in humans. Therefore, potential targets and procedures in the treatment of lung cancer could include EGFR-miRNA autophagy and cancer stem cell therapy in the presence of curcumin. Curcumin exerts its anticancer activity through multiple mechanisms, interfering with various cellular pathways and inducing the production of a variety of cytokines, enzymes or growth factors such as MAPK, EGF, NFκB.34 PKD1, COX-2, STAT3, TNF-α and IκKβ. Treatment with curcumin simultaneously reduced anticancer drug IC50 and stem cell counts. Also it was found to be good for treated breast cancer cell lines MBA-MB-231 and MCF-7 with paclitaxel, cisplatin or doxorubicin alone or in combination with curcumin or other natural compounds. Chemotherapy drugs reduce survival and curcamine reduces IC50 of experimental cell lines.35, 36, 37, 38 In a research on turmeric it was also demonstrated that curcumin reduced chemo resistance while increasing chemosensitivity of tumor cells. The law of Bcl-2-mediated apoptosis, including the PI3K and Wnt signaling pathways, may be the basis for these effects. The convenience of the Bcl-2 protein is an important factor for the development of drug resistance. By combining with other apoptosis-related proteins, Bcl-2 inhibits the tumor suppressor effects of drugs and promotes drug resistance.39 Anti-cancer activity of turmeric against a variety of human cancers. The anticancer mechanism of curcumin involves the regulation of multiple signaling pathways. Numerous experiments have demonstrated that curcumin can modulate the Wnt/β-catenin, PI3K/Akt, JAK/STAT, MAPK, p53 and NF-ĸB signaling pathways in cancer cells.40 Curcumin also possesses apoptotic and autophagic pathways. Curcumin may show the development of chemoresistance due to its multitarget activity in cancer. The effects of curcumin were studied in a dose-responsive experiment. The proliferation of MCF7 cells was significantly inhibited by curcumin in a concentration-dependent manner for 48 h (P < 0.01). Different concentrations of curcumin after 48 h had different cytotoxic effects on the MCF7 cell line.41

Figure 3

Concentration

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5a7927f3-5539-425e-aa3c-28159f98c329image3.png

It has been proven that cancer is the second leading cause of death in the world and one of the major public health problems. With great advances in cancer treatment, cancer morbidity and mortality rates remain high. The search for more effective and less toxic cancer treatment strategies is at the forefront of current research42, 43, 44, 45, 46 The research in this regard, the effects of numerous common fruit, herb, and vegetable extracts on the in vitro viability of two human ovary cancer cell lines (SKOV-3 and PEO1) were investigated.43 In another research turmeric was evaluated the in vitro anti-tumor potential (human thyroid cancer cell line) of curcumin and elucidated its molecular mechanism. Here, we investigated the effects of curcumin on cell viability, apoptosis, migration and invasion of the human thyroid cancer cell lines FTC133. Polyphenols and other natural substances have been found by Kashifa et.al from turmeric have the ability to affect cancer cells without causing negative side effects.47 They increase chemosensitivity, have higher absorption capacity, and can combat and reduce multidrug resistance. Neuroprotective effects of demethoxycurcumin, a natural derivative of curcumin on neurotoxicity induced by rotenone in the cells of SH-SY 5Y neuroblastoma have been found positive.48 T. Liu et al. found that human CD44+/CD133+ prostate cancer stem cells (HuPCaSC) were isolated from the prostate cancer cell lines Du145 and 22RV1,49, 50 Curcumin treatment of these cells resulted in inhibition of proliferation and invasion in vitro and cell cycle arrest.51 Turmeric oil and curcumin, derived from Curcuma Longa. 52, 53, 54

Conclusion

Curcumin has been recognized as a complex weapon in the fight against cancer, a deadly disease, due to its effects on key cell cycle signaling pathways and its effectiveness in animal model systems. Curcumin is a natural phytochemical that can interact with these new targets and aid chemotherapy. A wide range of important chemicals, including starches, proteins, vitamins, volatile oils and the main components of curcumin and curcuminoids, have been identified through phytochemical research on turmeric. These compounds have been shown to have many potent pharmacological properties. This review renews the impetus for the use of turmeric as a treatment and prevention approach of cancer.

Source of Funding

None.

Conflict of Interest

None.

Acknowledgment

The Authors RPN and SB thank the Author, and their UG Supervisor AGN for his genuine support. The Author AGN acknowledges Shri R. S.Yadav, President, CAYMET and Dr. R.K. Dumbre of CAYMET’s Siddhant College of Pharmacy for their due moral support.

References

1 

S Chanda TV Ramachandra Phytochemical and pharmacological importance of turmeric (Curcuma longa): A reviewRes Rev A J Pharmacol2019911623

2 

RK Verma P Kumari RK Maurya V Kumar RB Verma RK Singh Medicinal properties of turmeric (Curcuma longa L.): A reviewInt J Chem Stud201864135461

3 

H Nasri N Sahinfard M Rafieian S Rafieian M Shirzad MR Kopaei Turmeric: A spice with multifunctional medicinal propertiesJ Herb Med Pharmaco20143158

4 

M Akram AA Shahab-Uddin KH Usmanghani AB Hannan E Mohiuddin M Asif Curcuma longa and curcumin: a review articleRom J Biol Plant Biol20105526570

5 

O Wonkchalee T Boonmars C Aromdee P Laummaunwai W Khunkitti K Vaeteewoottacharn Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasisParasitol Res2012111135362

6 

SF Nabavi M Daglia AH Moghaddam S Habtemariam SM Nabavi Curcumin and Liver Disease: from Chemistry to MedicineCompr Rev Food Sci Food Saf20141316277

7 

L Labban Medicinal and pharmacological properties of Turmeric (Curcuma longa): A reviewInt J Pharm Biomed Sci2014511723

8 

EA Hashish SA Elgaml Hepatoprotective and Nephroprotective Effect of Curcumin Against Copper Toxicity in RatsIndian J Clin Biochem20163132707

9 

R Kuttan P Bhanumathy K Nirmala MC George Potential anticancer activity of turmeric (Curcuma longa).Cancer lett1985292197202

10 

BM Razavi G Rahbardar M Hosseinzadeh A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patentsPhytother Res202135126489513

11 

GK Jayaprakasha JM Rao L Sakariah Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcuminJ Agricul Food Chem20025013366872

12 

H Jiang BN Timmermann DR Gang Use of liquid chromatography-electrospray ionization tandem mass spectrometry to identify diarylheptanoids in turmeric (Curcuma longa L.) rhizomeJ Chromatography 2006111112131

13 

WR Farida F Shidiq N Inayah TH Handayani Effect of turmeric (Curcuma longa Linnaeus) and ginger (Zingiber officinale Roscoe) powder in feed on nutrient digestibility and performance of sunda porcupineInIOP Conf Series: Earth Environ Sci2021788112056

14 

AA Momtazi-Borojeni E Abdollahi B Nikfar S Chaichian ME Hundrieser Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapyHeart Failure Rev2019243399409

15 

RP Yadav G Tarun C Roshan P Yadav Versatility of turmeric: A review the golden spice of lifeJ Pharmacogn Phytochem20176147

16 

KP Nair Turmeric: origin and history. InTurmeric (Curcuma longa L.) and Ginger (Zingiber officinale Rosc.)-World's Invaluable Medicinal SpicesSpringer201916

17 

WL Chen YB Lin YW Lin R Chen JK Liao FL Ng AgriTalk: IoT for precision soil farming of turmeric cultivationIEEE Internet of Things J2019133520932

18 

K Singletary Turmeric: an overview of potential health benefits.Nutrition Today201045521641

19 

K Singletary Turmeric: potential health benefits. Nutrition Today20205514556

20 

E Hay A Lucariello M Contieri T Esposito De Luca A Guerra Therapeutic effects of turmeric in several diseases: An overviewChemico Biol Interact2019310110872910.1016/j.cbi.2019.108729

21 

A Hassan Curcuma longa, turmeric: a monographAust J Med Herbalism20061826676

22 

GN Asher K Spelman Clinical utility of curcumin extract. Altern Ther Health Med2013192146

23 

PR Waghmare PG Kakade PL Takdhat AM Nagrale SM Thakare MM Parate Turmeric as medicinal plant for the treatment of acne vulgaris.PharmaTutor2017541927

24 

V Dejonckheere Turmeric for Osteoarthritis in Veterinary Medicine: a Review. Veterinary Chiropractic Care, Acupuncture and Herbal Medicine2016116

25 

M Anushri R Yashoda MP Puranik Herbs: A good alternatives to current treatments for oral health problems. dermatitis (from topical application)Int J Adv Health Sci2015112912

26 

L Labban Medicinal and pharmacological properties of Turmeric (Curcuma longa): A reviewInt J Pharm Biomed Sci2014511723

27 

R Kuttan P Bhanumathy K Nirmala MC George Potential anticancer activity of turmeric (Curcuma longa). Cancer lett1985292197202

28 

NM Khanna Turmeric-Nature's precious gift. Curr Sci19997613517

29 

VR De Porras S Bystrup AM Cardus A Ginés L Layos JL Manzano Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathwayCancer Res2015755478

30 

BB Aggarwal S Banerjee U Bharadwaj B Sung S Shishodia G Sethi Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell linesBiochem Pharmacol2007737102432

31 

RK Srivastava Q Chen I Siddiqui K Sarva S Shankar Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1)Cell Cycle2007623295361

32 

SM Meeran SK Katiyar Cell cycle control as a basis for cancer chemoprevention through dietary agentsCell cycle control as a basis for cancer chemoprevention through dietary agents200813219120210.2741/2834

33 

DB Singh AK Maurya D Rai Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical StudiesAntibacterial and anticancer activities of turmeric and its active ingredient curcumin, and mechanism of action1Bentham Science PublishersSharjah, UAE201974103

34 

R Sumirtanurdin S Sungkar Y Hisprastin KD Sidharta DD Nurhikmah Molecular docking simulation studies of curcumin and its derivatives as cyclin-dependent kinase 2 inhibitorsTurkish J Pharm Sci202017441723

35 

HW Lai SY Chien SJ Kuo LM Tseng HY Lin CW Chi The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin.Evid Based Complement Altern Med201217447123

36 

A Shehzad YS Lee Molecular mechanisms of curcumin action: signal transductionBiofactors20133912736

37 

J Ye H Piao J Jiang JG Zheng M Yang Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways.Sci Rep20177113

38 

X Guo X Ding Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathwaysOncol Lett2018156953779

39 

M A. Al-Sha'er Zarqa Could the cancer be a chronic immune disorder? rather than a serious malignant diseaseDer Pharma Chem2014621408

40 

JK Lin Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin.Arc Pharmacal Res200427768392

41 

A Simon DP Allais JL Duroux JP Basly SD Fontanier C Delage Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships.Cancer lett1998311117

42 

R Kuttan P Bhanumathy K Nirmala MC George Potential anticancer activity of turmeric (Curcuma longa).Cancer lett1985292197202

43 

A Nair A Amalraj J Jacob AB Kunnumakkara S Gopi Non-curcuminoids from turmeric and their potential in cancer therapy and anticancer drug delivery formulationsBiomolecules2019911310.3390/biom9010013

44 

DP Shukla KP Shah RM Rawal NK Jain Anticancer and cytotoxic potential of turmeric (Curcuma longa), neem (Azadirachta indica), tulasi (Ocimum sanctum) and ginger (Zingiber officinale) extracts on HeLa cell lineInt J Life Sci Sci Res2016230924

45 

SK Vemuri RR Banala GP Subbaiah SK Srivastava AG Reddy T Malarvili Anti-cancer potential of a mix of natural extracts of turmeric, ginger and garlic: A cell-based studyEgyptian J Basic Appl Sci20174433276

46 

K Thanki RP Gangwal AT Sangamwar S Jain Oral delivery of anticancer drugs: challenges and opportunitiesJ Controlled Rel201317011540

47 

K Fathima J Lavanya V Jamal S Ahmed The Effectiveness of Various Chemotherapeutic Agents in Cancer TreatmentCurr Pharmacol Rep20222317

48 

Di Meo F Margarucci S Galderisi U Crispi S Peluso Curcumin, gut microbiota, and neuroprotectionNutrients2019111024266

49 

MM Wei SJ Zhao XM Dong YJ Wang C Fang P Wu A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cellsJ Ethnopharmacol202126711346710.1016/j.jep.2020.113467

50 

LR Chaudhary KA Hruska Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cellsJ Cell Biochem200389115

51 

J Sha J Li W Wang L Pan J Cheng L Li Curcumin induces G0/G1 arrest and apoptosis in hormone independent prostate cancer DU-145 cells by down regulating Notch signalingBiomed Pharmacother2016841778410.1016/j.biopha.2016.09.037

52 

JN Jacob M Toloue Biological studies of turmeric oil, Part 1: Selective in vitro anticancer activity of turmeric oil (TO) and TO-paclitaxel combinationNat Prod Commun2013861934578

53 

R Hamidpour S Hamidpour M Hamidpour M Sohraby M Hamidpour Curcuma longa): from a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetesInt J Pharmacol Phytochem Ethnomed2015113745

54 

R Ahmad AN Srivastava MA Khan Evaluation of in vitro anticancer activity of rhizome of Curcuma longa against human breast cancer and Vero cell linesEvaluation20161116



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

10-15


Authors Details

Amit Gajanan Nerkar, Rushikesh Nagarkar, Shubhangi Badar


Article History

Received : 20-02-2023

Accepted : 10-03-2023


Article Metrics


View Article As

 


Downlaod Files